![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Cierra Reports 'Non-Implant' Cardiac Catheter PFO Closure
Cierra Reports 'Non-Implant' Cardiac Catheter PFO Closure
April 19, 2005
Cierra announces the successful treatment of the first set of patients with their groundbreaking PFX Closure System for the treatment and closure of Patent Foramen Ovale (PFO). The Cierra PFX system is the first catheter based treatment in the world to close PFO without leaving behind a permanent implant.
Scotsman.com (http://news.scotsman.com/latest.cfm?id=4420229)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct